Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis

Iván Ferraz-Amaro1, Javier Rueda-Gotor2, Fernanda Genre3

  • 1Division of Rheumatology, Hospital Universitario de Canarias, Ofra sn, Tenerife, 38320, Spain.

Insights

Increased cardiovascular (CV) risk factors in axial spondyloarthritis (axSpA) patients are linked to higher disease activity. Managing CV risk factors may help control axSpA progression.

Area of Science:

  • Rheumatology
  • Cardiology
  • Epidemiology

Background:

  • Axial spondyloarthritis (axSpA) is associated with increased prevalence of comorbidities like atherosclerosis, hypertension, dyslipidemia, and diabetes.
  • Understanding the link between traditional cardiovascular (CV) risk factors and disease characteristics in axSpA is crucial for patient management.

Purpose of the Study:

  • To investigate the relationship between the number of traditional CV risk factors and disease characteristics, specifically disease activity, in patients with axSpA.

Main Methods:

  • A cross-sectional study involving 804 axSpA patients.
  • Assessment of five traditional CV risk factors: diabetes mellitus, dyslipidemia, hypertension, obesity, and smoking status.
  • Multivariable regression analysis to determine the independent association between CV risk factors and disease activity.

Main Results:

  • Higher Ankylosing Spondylitis Disease Activity Score-C reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores were observed with an increasing number of CV risk factors.
  • Patients with one or more CV risk factors showed significantly higher disease activity scores and odds of high disease activity compared to those with none.
  • A dose-dependent effect was noted, with higher CV risk factor burden correlating with increased disease activity.

Conclusions:

  • The number of traditional CV risk factors independently correlates with increased disease activity in axSpA patients.
  • This suggests a potential therapeutic target for managing axSpA by addressing modifiable CV risk factors.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
122
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
138
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
538
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
534
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
128
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
75